Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

Senator Josh Hawley wants Congress to revoke the FDA's approval of mifepristone and ban the abortion pill nationally. His bill has stalled in committee, and in September he began pressing Republicans to sign a pledge backing it.

Case period:

Published by The Dispute Index editorial teamPublished Updated

Overview

The fixed reference point for classification in this case is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Responses are recorded against that proposition, not against abortion generally and not against the separate question of whether the Trump administration should act through the FDA.

The bill is S. 4066 (opens in a new tab), introduced March 11, 2026 and referred to the Senate Health, Education, Labor and Pensions Committee, where it remains. Its seven Republican cosponsors joined on staggered dates: John Cornyn (March 12), Marsha Blackburn (March 18), Ted Budd (March 23), Tommy Tuberville (March 25), Bernie Moreno (April 15), James Lankford (April 20) and Mike Rounds (June 23). None has withdrawn, and none has joined since June. The identical House companion, H.R. 7902, was introduced by Diana Harshbarger on March 12, 2026 and is likewise unmoved. Cosponsorship is a legislative act rather than a public statement; of the seven, only Cornyn has made an attributed public comment, which is recorded separately.

Hawley's central safety claim, that roughly one in ten women suffer serious complications, rests on a 2025 paper from the Ethics and Public Policy Center. PolitiFact (opens in a new tab) reported that the paper was not peer reviewed, did not disclose its data source, and was criticised by more than 250 reproductive health researchers; recategorised under the FDA's own definitions the same data yields rates of 0.10 percent for sepsis, 0.15 percent for blood transfusion and 0.22 percent for life-threatening events. The FDA has said it has identified no new safety concerns with the drug. DI records this because both sides argue from it, not to settle the dispute.

Susan Collins and Lisa Murkowski were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown, and their spokespeople did not answer questions about this bill. Non-response is not a position and no record is created for it.

People in this case

The newsletter

The claim. The original source. What changed.

Get DI’s new cases and significant updates in your inbox. Subscribe free.

You'll complete your subscription on Substack.

Timeline

3 timeline entries on this page. Dates: March 11, 2026 to September 16, 2026

  1. March 2026

    1 event

    1. Hawley introduces the Safeguarding Women from Chemical Abortion Act

      Incident

      Senator Josh Hawley introduced S. 4066, the Safeguarding Women from Chemical Abortion Act, and announced it at a Capitol Hill press conference with anti-abortion movement leaders. The bill would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. It was referred to the Senate Committee on Health, Education, Labor and Pensions. An identical House companion, H.R. 7902, was introduced by Representative Diana Harshbarger the following day.

      [01]S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress

      The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack API (bill 428713) on September 18, 2026, because congress.gov blocked automated retrieval: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

      S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
      [02]Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders

      Source excerpt

      The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse.

      Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

      Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
  2. 104 days between recorded events

    June 2026

    1 event

    1. Seven Republican senators cosponsor the bill over three months, then recruitment stops

      Incident

      Seven Republican senators signed on as cosponsors of S. 4066 on staggered dates: John Cornyn on March 12, Marsha Blackburn on March 18, Ted Budd on March 23, Tommy Tuberville on March 25, Bernie Moreno on April 15, James Lankford on April 20 and Mike Rounds on June 23. None subsequently withdrew, and no further senator joined after that date. The bill received no committee action. Cosponsorship is a legislative act rather than a public statement, and of the seven only Cornyn has made an attributed public comment on the bill.

      [01]S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress

      The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack API (bill 428713) on September 18, 2026, because congress.gov blocked automated retrieval: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

      S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
  3. 85 days between recorded events

    September 2026

    1 event

    1. Hawley unveils a "Declaration for Life" pledge and asks candidates to sign it

      Incident

      At the close of the first Missouri Prayer Breakfast, held in the Kennedy Caucus Room of the Russell Senate Office Building, Hawley unveiled a four-page "Declaration for Life" drafted by more than 30 pastors and signed by more than 100 Missouri pastors and about 50,000 citizens. The document calls on Congress to ban mifepristone, arguing that state abortion restrictions are insufficient because the drug can be mailed across state lines. Hawley said he would ask officeholders and candidates in both parties to sign it. Tony Perkins of the Family Research Council and the Christian musician Sean Feucht joined him at the unveiling. Reporting at the time noted the bill had not received much discussion within the Senate Republican conference since its introduction.

      [03]Hawley Unveils Declaration for Life with Christian Leaders

      Source excerpt

      This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion.

      The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."

      Hawley Unveils Declaration for Life with Christian Leaders · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
      [04]Hawley to push GOP officeholders, candidates to sign 'Declaration for Life'

      Source excerpt

      Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it.

      Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The page blocks automated retrieval; its full text was obtained through the Firecrawl index on September 18, 2026, and the same quotations appear in the syndicated version carried by Yahoo News.

      Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

Response record

Responses

Latest recorded positions: 10. Dates: March 12, 2026 to September 16, 2026

Choose one response filter, or select All responses to see the full record.

3 responses on this page

  1. Jon Husted
    "Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it."
    Open source (opens in a new tab)Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Why this label?

    The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Husted was asked directly for his position and withheld it, which is a refusal rather than a substantive response. The closest competing label is a finding that this is not a position event at all, since not having read a bill can be a plain statement of fact rather than an evasion. That loses because the question put to him was expressly for his position, and Axios reported the answer as one of several from senators in competitive races who would not state one. This record carries a lower grade of evidence than the others in the case: the source paraphrases rather than quotes, so the substance is attributable to Husted but the wording is the reporter's.

    This label describes the statement’s response within the context above.

    Read context and background

    Asked by Axios for his position on Hawley's bill to ban mifepristone, Senator Jon Husted said he had not seen it. Axios reported his answer in paraphrase and did not publish a direct quotation, so no words of Husted's own are on the record; the excerpt held here is the reporter's sentence, quoted verbatim from the source. Husted was facing a competitive reelection race in Ohio at the time.

    Role at the time: United States Senator for Ohio, responding to questions from Axios; his answer is reported in paraphrase, not quoted directly

    Before the statement

    Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms, and that additional abortion restrictions could cost the party support in key races. It approached senators in competitive races for their positions.

    After the statement

    Senator Thom Tillis gave Axios the same answer, adding "No" when asked whether Republicans were discussing the issue at all. Senate health committee chairman Bill Cassidy separately told MS NOW he had not seen the legislation.

    Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
  2. Thom Tillis
    "No."
    Open source (opens in a new tab)Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Why this label?

    The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Tillis withholds a position on the bill and then closes down the broader subject, which is a refusal rather than a substantive response. The closest competing label is a finding that this is not a position event at all, since not having read a bill can be a simple statement of fact. That loses because the exchange was an express request for his position and he declined it twice, the second time foreclosing discussion of the issue itself.

    This label describes the statement’s response within the context above.

    Read context and background

    Asked by Axios for his position on Hawley's bill, Senator Thom Tillis said he had not seen it. Asked whether Republicans were talking about the issue in general, he answered no.

    Role at the time: United States Senator for North Carolina, responding to questions from Axios

    Before the statement

    Axios reported that additional abortion restrictions could cost Republicans support in competitive races, and approached senators in such races for their positions.

    After the statement

    Senator Jon Husted, who also faced a competitive reelection race, gave Axios the same answer about the bill; his response is recorded separately, though the report paraphrases rather than quotes him.

    Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
  3. Bill CassidyDirectly involved
    "I haven't seen this particular legislation."
    Open source (opens in a new tab)Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Why this label?

    The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Asked directly for his position on the bill, Cassidy closed the question by saying he had not seen it, while stating a general view on abortion pill availability. That is a refusal to take a position on the specific proposal. The closest competing label is defends_or_excuses, because he volunteered that he opposes the drug's current availability. That loses because the case's reference point is the congressional ban, not availability in the abstract; his general remark does not commit him to the bill, and the operative part of the answer withholds a position on it.

    This label describes the statement’s response within the context above.

    Read context and background

    Asked about Hawley's bill, Senator Bill Cassidy, chairman of the Senate Health, Education, Labor and Pensions Committee to which it had been referred, told MS NOW that he opposes the current scope of availability of abortion pills, then added that he had not seen this particular legislation. He has not said whether his committee will take the bill up.

    Role at the time: United States Senator for Louisiana and chairman of the Senate Committee on Health, Education, Labor and Pensions, responding to questions from MS NOW

    Before the statement

    S. 4066 had been referred to Cassidy's committee the previous day. He had held a hearing in January on what he called the dangers of mifepristone and had joined an amicus brief on the drug's dispensing rules. He was facing a primary challenge.

    After the statement

    The bill has received no committee action in the six months since. A Cassidy spokesperson referred questions to the senator's past work on the issue.

    Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

Sources

(8)

Original text

S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress

S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress (opens in a new tab) · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
Read source (opens in a new tab)

Relevant passage: S. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.

About this source

The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack API (bill 428713) on September 18, 2026, because congress.gov blocked automated retrieval: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

Published
Accessed
Archived copy (opens in a new tab)

Official statement

Senate Introduces Attack on Mifepristone

Senate Introduces Attack on Mifepristone (opens in a new tab) · Physicians for Reproductive HealthOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.
Read source (opens in a new tab)

Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.

Excerpt

"the science is clear: mifepristone is safe, mifepristone is effective, and mifepristone is still medically indicated"

About this source

The response from a national physicians' organization, answering Hawley's safety claim on clinical grounds. Perritt's phrasing deliberately mirrors Hawley's own "the science is clear" formulation from the bill announcement.

Published
Accessed

Official statement

Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone

Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone (opens in a new tab) · Reproductive Freedom for AllOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.
Read source (opens in a new tab)

Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.

Excerpt

"Let's not forget: Senator Hawley's own constituents voted to protect abortion access. But he and his extremist colleagues will not stop until they've banned abortion nationwide."

About this source

The organization's official response to the bill, notable for grounding its objection in the 2024 Missouri ballot measure protecting abortion access in Hawley's own state.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms

Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms (opens in a new tab) · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.
Read source (opens in a new tab)

Relevant passage: MS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

Excerpt

"When asked, Sen. Bill Cassidy, R-La., chairman of the Health, Education, Labor and Pensions Committee, told MS NOW on Thursday he opposes the current scope of availability of abortion pills — before adding, "I haven't seen this particular legislation.""

About this source

Source for Bill Cassidy's response as chairman of the committee holding the bill, John Cornyn's "All in" post on X, Chuck Schumer's reaction, and Alexis McGill Johnson's statement. Also records that spokespeople for Susan Collins and Lisa Murkowski did not respond to questions about the bill, and that the two were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Hawley's abortion pill move puts Republican senators in a bind

Hawley's abortion pill move puts Republican senators in a bind (opens in a new tab) · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
Read source (opens in a new tab)

Relevant passage: Axios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

Excerpt

"Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it. Sen. Thom Tillis (R-N.C.) likewise said he had not seen the bill."

About this source

The fullest available account of Senate Republican reluctance on the bill, with direct responses from Husted and Tillis, Hawley's reply to Axios, and Marjorie Dannenfelser's criticism of the Trump administration's handling of mifepristone litigation.

Author
Peter Sullivan
Published
Accessed
Archived copy (opens in a new tab)

Reporting

Hawley to push GOP officeholders, candidates to sign 'Declaration for Life'

Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' (opens in a new tab) · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.
Read source (opens in a new tab)

Relevant passage: The Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

Excerpt

"Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it."

About this source

Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The page blocks automated retrieval; its full text was obtained through the Firecrawl index on September 18, 2026, and the same quotations appear in the syndicated version carried by Yahoo News.

Author
Alexander Bolton
Published
Accessed

Official statement

Hawley Unveils Declaration for Life with Christian Leaders

Hawley Unveils Declaration for Life with Christian Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
Read source (opens in a new tab)

Relevant passage: Official Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.

Excerpt

"This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion."

About this source

The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."

Author
Office of Senator Josh Hawley
Published
Accessed

Official statement

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
Read source (opens in a new tab)

Relevant passage: Official Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

Excerpt

"The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."

About this source

Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

Author
Office of Senator Josh Hawley
Published
Accessed
Archived copy (opens in a new tab)

Corrections

(0)

Corrections address errors in our reporting or labels. When a speaker changes their position, we add a separate statement and link it to the earlier one.

No corrections on this page.

The newsletter

The claim. The original source. What changed.

Get DI’s new cases and significant updates in your inbox. Subscribe free.

You'll complete your subscription on Substack.